The COVID Chemistry of a Perfect Match for SpeeDx and SynGenis


Manage episode 319732900 series 3009792
Van MTPConnect, ontdekt door Player FM en onze gemeenschap - copyright toebehorend aan de uitgever, niet aan Player FM. Audio wordt direct van hun servers gestreamd. Klik de abonneren-knop aan om updates op Player FM te volgen of plak de feed URL op andere podcast apps.

For our first episode of 2022, we look into a new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx. WA start-up SynGenis is the brainchild of Professor Rakesh Veedu, a world-renowned oligonucleotide chemical biologist. Sydney-based SpeeDx, led by CEO Colin Denver, is a privately owned company spun out of Johnson and Johnson that develops PCR testing solutions for infectious diseases including COVID-19. In the wake of the pandemic, SpeeDx faced a constrained supply of oligonucleotides which are a critical component of their diagnostic kits. MTPConnect brokered SpeeDx an introduction to SynGenis and the rest is history in the making!

132 afleveringen